Sanofi chief lays out distinctive strategy
Health / Medicine Related News
The chief executive of Sanofi-Aventis criticises the past dominance of science over commerce in the French pharmaceuticals group and the stifling of the companies it acquired, as he lays out a distinctive strategy almost one year into the job
Source: FT.com - Pharmaceuticals
A third major insulin maker, Sanofi, will cut the cost of the life-saving drug. Here's why it's been so expensive — and what's next. Sanofi was the final holdout among three companies that produce 90% of the world's insulin market by value. Earlier this week, Novo Nordisk followed Eli Lilly Co.'s plans to slash U.S. Prices by up to 75% and 70%, respectively. Source 8h.